1. Home
  2. BTA vs STTK Comparison

BTA vs STTK Comparison

Compare BTA & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Long-Term Municipal Advantage Trust of Beneficial Interest

BTA

BlackRock Long-Term Municipal Advantage Trust of Beneficial Interest

HOLD

Current Price

$9.55

Market Cap

125.7M

Sector

Finance

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$4.35

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTA
STTK
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.7M
119.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BTA
STTK
Price
$9.55
$4.35
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$4.00
AVG Volume (30 Days)
21.9K
638.6K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
5.22%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.59
$0.69
52 Week High
$10.62
$4.89

Technical Indicators

Market Signals
Indicator
BTA
STTK
Relative Strength Index (RSI) 51.06 60.59
Support Level $9.42 $4.10
Resistance Level $9.66 $4.80
Average True Range (ATR) 0.07 0.41
MACD 0.01 -0.05
Stochastic Oscillator 55.68 60.81

Price Performance

Historical Comparison
BTA
STTK

About BTA BlackRock Long-Term Municipal Advantage Trust of Beneficial Interest

Blackrock Long-term Municipal AdtgTrust is a diversified closed-end investment trust. Its investment objective is to provide current income exempt from regular U.S. federal income tax. The fund, under normal market conditions, invests a majority of its managed assets in municipal obligations and derivative instruments with exposure to such municipal obligations, in each case that are expected to pay interest or income that is exempt from U.S. federal income tax. Its investment portfolio comprises dollar-weighted, long-term municipal bonds with a maturity of more than ten years at the time of investment. The fund's investments have exposure to various sectors such as Corporate, Health, County/City/Special District/School District, Transportation, Education, Utilities, State, Tobacco, etc.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: